SurgePays Announces Underwritten Public Equity Offering Agreement
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SurgePays ( (SURG) ) has shared an announcement.
On January 20, 2026, SurgePays entered into an underwriting agreement with R.F. Lafferty & Co. for an underwritten public offering of 2 million shares of common stock at $1.25 per share, for anticipated gross proceeds of about $2.5 million, with a 45‑day option for the underwriter to purchase up to an additional 300,000 shares to cover any over‑allotments; closing was expected on January 22, 2026, when the company would deliver the shares and issue representative’s warrants equal to 3% of the total shares sold, exercisable six months after closing and running for five years. The financing, conducted under an existing shelf registration and accompanied by standard indemnification, lock‑up provisions for directors and officers, and a 180‑day restriction on new issuances without underwriter consent, is intended to fund expansion of SurgePays’ Lifeline business and general corporate purposes, while a concurrent prospectus supplement on January 20, 2026 updated the capacity of its at‑the‑market program with Titan Partners Group, further positioning the company to tap equity markets for ongoing capital needs.
The most recent analyst rating on (SURG) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on SurgePays stock, see the SURG Stock Forecast page.
Spark’s Take on SURG Stock
According to Spark, TipRanks’ AI Analyst, SURG is a Neutral.
The score is held down primarily by weak financial performance—deep losses, heavy cash burn, and negative equity—despite strong revenue growth. Offsetting factors include constructive near-term technicals and a more optimistic earnings-call outlook (rapid subscriber/revenue growth, narrowing gross loss, and lower SG&A), but valuation support is limited given negative earnings and no dividend yield provided.
To see Spark’s full report on SURG stock, click here.
More about SurgePays
SurgePays, Inc. operates in the telecommunications and fintech space, with a particular focus on its Lifeline business, which provides subsidized connectivity services to eligible low-income consumers. The company uses capital markets financing to support the expansion of this Lifeline segment and to fund general working capital and broader corporate needs.
Average Trading Volume: 186,442
Technical Sentiment Signal: Sell
Current Market Cap: $39.35M
For an in-depth examination of SURG stock, go to TipRanks’ Overview page.
